Document is current
Any future updates will be listed below
-
Authors
Kario, Kazuomi
Yokoi, Yoshiaki
Okamura, Keisuke
Fujihara, Masahiko
Ogoyama, Yukako
Yamamoto, Eiichiro
Urata, Hidenori
Cho, Jin-Man
Kim, Chong-Jin
Choi, Seung-Hyuk
Shinohara, Keisuke
Mukai, Yasushi
Ikemoto, Tomokazu
Nakamura, Masato
Seki, Shuichi
Matoba, Satoaki
Shibata, Yoshisato
Sugawara, Shigeo
Yumoto, Kazuhiko
Tamura, Kouichi
Yoshihara, Fumiki
Nakamura, Satoko
Kang, Woong Chol
Shibasaki, Taro
Dote, Keigo
Yokoi, Hiroyoshi
Matsuo, Akiko
Fujita, Hiroshi
Takahashi, Toshiyuki
Kang, Hyun-Jae
Sakata, Yasushi
Horie, Kazunori
Inoue, Naoto
Sasaki, Ken-ichiro
Ueno, Takafumi
Tomita, Hirofumi
Morino, Yoshihiro
Nojima, Yuhei
Kim, Chan Joon
Matsumoto, Tomoaki
Kai, Hisashi
Nanto, Shinsuke
- License Information
-
More Information
Article History
Received: 27 August 2021
Revised: 3 September 2021
Accepted: 7 September 2021
First Online: 15 October 2021
Compliance with ethical standards
:
: KK has received speaker fees and works as a consultant to Medtronic, JIMRO, Otsuka Medical Device and Terumo. YY has received consulting fees from JIMRO. KO has received honoraria and grant support from JIMURO. HU has received research grants from JIMRO. KS has received research grants from Daiichi-Sankyo and Nippon Boehringer Ingelheim. MN has received lecture fee from Terumo, Daiichi-Sankyo, Otsuka Medical Device and Tanabe Mitsubishi. KT has received consulting fees or speaking honorarium or both from Takeda, AstraZeneca, Novartis, Ono Pharmaceutical, Boehringer Ingelheim, Kyowa-kirin, Mochida, Daiichi-Sankyo, Astellas, Sanwa-Kagaku, Torii, Kowa, Eli Lilly, and has received operating funds from Otsuka Pharmaceutical, Takeda, Chugai, Kissei, Fuji, Kyowa-Kirin, Daiichi-Sankyo, Boehringer Ingelheim, Teijin, Dainippon-Sumitomo, Torii, Tanabe Mitsubishi, Merck Sharp & Dohme, and Bayer. HY has received honoraria from Otsuka Pharmaceutical, Terumo, Medicon, Daiichi-Sankyo, Nihon Medi-Physics and has received scholarship (educational) grant from Daiichi-Sankyo. HJK has received Patent royalties/licensing fees from Daewoong Pharma. YS has received lecture fee from Otsuka Pharmaceutical. KS has received lecture fee from Otsuka Pharmaceutical. HT has received research funding from Otsuka Pharmaceutical. YM has unrestricted received research grant and lecture fee from Otsuka Pharmaceutical. SN has received consultation fees from JIMRO, Otsuka Medical Devices, Kyocera, Terumo and MDK medical and has received trust research/joint research funds from Boston Scientific. All other authors declare no competing interests. PARADISE is a trademark of ReCor Medical, Inc. registered in the United States, the European Union, and Japan.
